These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11522028)

  • 21. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?
    Lobo RA; Whitehead MI
    Climacteric; 2001 Jun; 4(2):110-9. PubMed ID: 11428175
    [No Abstract]   [Full Text] [Related]  

  • 23. A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen.
    Vashisht A; Wadsworth F; Carey A; Carey B; Studd J
    Gynecol Endocrinol; 2005 Aug; 21(2):101-5. PubMed ID: 16109596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy for my menopausal patients. Is it better to use oral or transdermal hormones?
    Berliner S
    Explore (NY); 2006 Mar; 2(2):184. PubMed ID: 16781635
    [No Abstract]   [Full Text] [Related]  

  • 25. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Decensi A; Bonanni B; Baglietto L; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Robertson C; Marinucci I; Mariette F; Sandri MT; Daldoss C; Bianco V; Buttarelli M; Cazzaniga M; Franchi D; Cassano E; Omodei U
    Clin Cancer Res; 2004 Jul; 10(13):4389-97. PubMed ID: 15240527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.
    Kawano H; Nagayoshi Y; Soejima H; Tanaka Y; Hokamaki J; Miyamoto S; Miyazaki Y; Yamabe H; Ogawa H
    Menopause; 2008; 15(2):352-6. PubMed ID: 18090872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal natural progesterone cream for postmenopausal women: inconsistent data and complex pharmacokinetics.
    Elshafie MA; Ewies AA
    J Obstet Gynaecol; 2007 Oct; 27(7):655-9. PubMed ID: 17999287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term effect of transdermal estrogen on autonomic nervous modulation in postmenopausal women.
    Chao HT; Kuo CD; Su YJ; Chuang SS; Fang YJ; Ho LT
    Fertil Steril; 2005 Nov; 84(5):1477-83. PubMed ID: 16275247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implications for heart disease and diabetes risk.
    Godsland IF; Stevenson JC
    Br J Clin Pract Suppl; 1996 Sep; 86():1-5. PubMed ID: 8995002
    [No Abstract]   [Full Text] [Related]  

  • 32. Parenteral versus oral treatment of postmenopausal women with estrogen.
    Stanczyk FZ
    Menopause; 2007; 14(6):968-70. PubMed ID: 17898669
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study.
    Verhoeven MO; Hemelaar M; van der Mooren MJ; Kenemans P; Teerlink T
    J Intern Med; 2006 Feb; 259(2):199-208. PubMed ID: 16420549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol.
    Qureshi AC; Bahri A; Breen LA; Barnes SC; Powrie JK; Thomas SM; Carroll PV
    Clin Endocrinol (Oxf); 2007 May; 66(5):632-5. PubMed ID: 17492949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal hormone replacement therapy: its value in various clinical situations. Introduction.
    Br J Clin Pract Suppl; 1996 Sep; 86():i. PubMed ID: 8995001
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein.
    Lacut K; Oger E; Le Gal G; Blouch MT; Abgrall JF; Kerlan V; Scarabin PY; Mottier D;
    Thromb Haemost; 2003 Jul; 90(1):124-31. PubMed ID: 12876635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of hormone therapy on pulmonary function tests in postmenopausal women.
    Cevrioglu AS; Fidan F; Unlu M; Yilmazer M; Orman A; Fenkci IV; Serteser M
    Maturitas; 2004 Nov; 49(3):221-7. PubMed ID: 15488350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women?
    Easton BT
    J Fam Pract; 2001 May; 50(5):470. PubMed ID: 11350716
    [No Abstract]   [Full Text] [Related]  

  • 39. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M; Simoncini T; Fuller S; Genazzani AR
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
    Koh KK; Han SH; Shin MS; Ahn JY; Lee Y; Shin EK
    Eur Heart J; 2005 Jul; 26(14):1362-8. PubMed ID: 15872028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.